Oral beclomethasone dipropionate: a critical review of its use in the management of ulcerative colitis and Crohn's disease.

@article{Spurio2012OralBD,
  title={Oral beclomethasone dipropionate: a critical review of its use in the management of ulcerative colitis and Crohn's disease.},
  author={Federica Fasc{\`i} Spurio and Annalisa Aratari and Giovanna Margagnoni and Maria Teresa Doddato and Francesca Chiesara and C Cortez Papi},
  journal={Current clinical pharmacology},
  year={2012},
  volume={7 2},
  pages={
          131-6
        }
}
Crohn's disease and ulcerative colitis are inflammatory bowel diseases characterised by a chronic relapsing course. Corticosteroids represent the mainstay of medical treatment of inflammatory bowel disease for the induction of remission. Despite the high efficacy of systemic steroids, their use is limited by the high incidence of potentially serious adverse effects. The topically acting steroids are synthetic compounds characterised by high anti-inflammatory activity and low systemic effects by… CONTINUE READING
BETA